BAG3+ CAF-T cell neighborhood predicts resistance to neoadjuvant chemoimmunotherapy in NSCLC - Top-Institutions - MDSpire

BAG3+ CAF-T cell neighborhood predicts resistance to neoadjuvant chemoimmunotherapy in NSCLC

  • By

  • Jing Sun

  • Zhengqi Cao

  • Yueping Jin

  • Anni Wang

  • Li Lu

  • Lixuan Chen

  • Wenhui Shi

  • Peiyi Xu

  • Yuxin Ouyang

  • Junjie Tang

  • Zhouwenli Meng

  • Ziming Li

  • July 7, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Shanghai Chest Hospital
    Shanghai Chest Hospital

    Shanghai, China

    Key Differentiators

    • Oncology

  • #3

    MD Anderson’s Institute for Data Science in Oncology (IDSO)
    MD Anderson’s Institute for Data Science in Oncology (IDSO)

    Houston, Texas

    Key Differentiators

    • Oncology

  • #4

    Department of Breast Medical Oncology
    Department of Breast Medical Oncology

    Houston, Texas

    Key Differentiators

    • Oncology

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Oncology

Original Source(s)

BAG3+ CAF-T cell neighborhood predicts resistance to neoadjuvant chemoimmunotherapy in NSCLC

  • by Jing Sun, Zhengqi Cao, Yueping Jin, Anni Wang, Li Lu, Lixuan Chen, Wenhui Shi, Peiyi Xu, Yuxin Ouyang, Junjie Tang, Zhouwenli Meng, Ziming Li

  • July 7, 2026

Related Content

Advances in the multimodal management of central nervous system solitary fibrous tumors

Case Report: Pediatric Philadelphia chromosome-positive T-lymphoblastic leukemia relapsing as chronic-phase CML after treatment discontinuation

Bridging the gap in pediatric cancer rehabilitation care: a multi-perspective survey study